Literature DB >> 6312489

Characterization of leukotriene A4 and B4 biosynthesis.

B A Jakschik, C G Kuo.   

Abstract

We have studied LTA4 and LTB4 synthesis in a cell-free system from RBL-1 cells. All the enzymes leading to the formation of LTB4 from arachidonic acid are localized in the soluble fraction (100,000 x g supernatant) of these cells. The formation of LTA4 and LTB4 is complete by 10 min. When we varied the arachidonic acid concentration from 1 to 300 microM, the synthesis of LTB4 leveled off at 30 microM and of LTA4 at 100 microM while 5-HETE had not reached a plateau at 300 microM. This enzyme system has the capacity to generate relatively large amounts of 5-HETE and LTA4 and only a relatively small amount of LTB4. Therefore, the rate limiting step is not the 5-lipoxygenase, the first step in the pathway, but the conversion of LTA4 to LTB4. This is in contrast to cyclooxygenase pathway where the first step is rate limiting. A second addition of arachidonic acid at submaximal concentration for LTA4 synthesis did not produce any additional LTA4 or LTB4. Further study of this phenomenon showed that the 5-lipoxygenase and LTA-synthase were inactivated with time by preincubation with arachidonic acid and that peroxy fatty acids seem to be the inactivating species.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6312489     DOI: 10.1016/0090-6980(83)90002-3

Source DB:  PubMed          Journal:  Prostaglandins        ISSN: 0090-6980


  11 in total

1.  LTA4 hydrolase in human skin: decreased activity, but normal concentration in lesional psoriatic skin. Evidence for different LTA4 hydrolase activity in human lymphocytes and human skin.

Authors:  L Iversen; B Deleuran; A M Hoberg; K Kragballe
Journal:  Arch Dermatol Res       Date:  1996-05       Impact factor: 3.017

2.  Serum-induced differentiation of human meibomian gland epithelial cells.

Authors:  David A Sullivan; Yang Liu; Wendy R Kam; Juan Ding; Karin M Green; Scott A Shaffer; Mark P Hatton; Shaohui Liu
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-05-27       Impact factor: 4.799

3.  Leukotriene B5 is formed in human neutrophils after dietary supplementation with icosapentaenoic acid.

Authors:  T Strasser; S Fischer; P C Weber
Journal:  Proc Natl Acad Sci U S A       Date:  1985-03       Impact factor: 11.205

4.  Characterization of leukotriene A4 synthase from murine mast cells: evidence for its identity to arachidonate 5-lipoxygenase.

Authors:  T Shimizu; T Izumi; Y Seyama; K Tadokoro; O Rådmark; B Samuelsson
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

5.  Isolation and characterization of leukotriene C4 synthetase of rat basophilic leukemia cells.

Authors:  T Yoshimoto; R J Soberman; R A Lewis; K F Austen
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

6.  Evaluation of 5- and 6-fluoro derivatives of arachidonic acid and 5,8,14-eicosatrienoic acid as substrates and inhibitors of 5-lipoxygenase.

Authors:  J F Navé; D Jacobi; C Gaget; B Dulery; J B Ducep
Journal:  Biochem J       Date:  1991-09-01       Impact factor: 3.857

7.  Leukotriene A4 hydrolase in human bronchoalveolar lavage fluid.

Authors:  D A Munafo; K Shindo; J R Baker; T D Bigby
Journal:  J Clin Invest       Date:  1994-03       Impact factor: 14.808

Review 8.  Lymphatic Dysfunction, Leukotrienes, and Lymphedema.

Authors:  Xinguo Jiang; Mark R Nicolls; Wen Tian; Stanley G Rockson
Journal:  Annu Rev Physiol       Date:  2017-10-13       Impact factor: 19.318

9.  Combined Machine Learning and GRID-Independent Molecular Descriptor (GRIND) Models to Probe the Activity Profiles of 5-Lipoxygenase Activating Protein Inhibitors.

Authors:  Hafiza Aliza Khan; Ishrat Jabeen
Journal:  Front Pharmacol       Date:  2022-03-01       Impact factor: 5.810

10.  Systemic leukotriene B4 receptor antagonism lowers arterial blood pressure and improves autonomic function in the spontaneously hypertensive rat.

Authors:  Paul J Marvar; Emma B Hendy; Thomas D Cruise; Dawid Walas; Danielle DeCicco; Rajanikanth Vadigepalli; James S Schwaber; Hidefumi Waki; David Murphy; Julian F R Paton
Journal:  J Physiol       Date:  2016-07-08       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.